Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marlin Global Limited Director's Dealing 2021

May 20, 2021

66231_rns_2021-05-20_da21394e-7839-40bb-8302-6c808cdf1d9c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [98 x 27] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

ToNZX Limited; and
Name of listedissuer: MarlinGlobal Limited
Date this disclosuremade: 20-May-21
Date of last disclosure: 30-Mar-21
Director or senior manager giving disclosure
Full name(s): Alistair BruceRyan
Name of listedissuer: MarlinGlobal Limited
Name of related body corporate (ifapplicable): n/a
Position heldin listedissuer: Director
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class ofaffected quotedfinancialproducts:
Nature ofthe affectedrelevantinterest(s):
For that relevant interest-
Number heldinclass before acquisitionordisposal:
Number heldinclass afteracquisitionordisposal:
Currentregisteredholder(s):
Registeredholder(s) once transfers areregistered:
Summary of acquisition or disposal of specified derivatives relevant interest (ifapplicab le)
Type ofaffected derivative: Warrants
Class ofunderlyingfinancialproducts: Ordinary Shares
The notional value of the derivative (if any) or the notional amount of underlying financial
products (ifany):
$8,289.50 (33,158 warrants @ $0.25
warrant price)
Astatement as towhetherthe derivativeis cashsettled orphysically settled: Cashsettled
Maturity date ofthe derivative (ifany): 20-May-22
Expiry date ofthe derivative(ifany): 20-May-22
The price specified in the terms of the derivative (if any): $1.28 less dividends declared over the
period.
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
n/a
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interestinthe derivative:
Parties to the derivative: Alistair Ryan& JLOA/C
If the director or senior manager is not a party to the derivative, the nature of the relevant
interestinthe derivative:
n/a
Details of transactions giving rise to acquisition or disposal
Total numberoftransactions towhich noticerelates: One
17-May-21
Issue of 33,158 warrants pursuant to the
warrant terms announced on 19 April
2021.
None
Nil (warrants issued for no cost to all
shareholders on the record date of 14
May2021)
One
Whether relevantinterestswere acquired ordisposed ofduring a closed period: Not during closed period
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
n/a
Date ofthe prior writtenclearance (ifany): n/a
Summary of other relevant interests after acquisition or disposal:
Class ofquotedfinancialproducts:
Nature of relevantinterest:
For that relevant interest,-
Number heldinclass:
Ordinary Shares
Registeredholderand beneficialowner
Number heldinclass: 132,629 ordinary shares
Alistair Ryan& JLOA/C
The notional value of the derivative (if any) or the notional amount of underlying financial
products (ifany):
Astatement as towhetherthe derivativeis cashsettled orphysically settled:
Maturity date ofthe derivative (ifany):
Expiry date ofthe derivative (ifany):
The price's specified terms (ifany):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlyingfinancialproducts:
_For that derivative relevant interest,- _
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant
interestinthe derivative:

Certification

I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorised person:

==> picture [106 x 25] intentionally omitted <==

20-May-21